Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
Global E-Clinical Solutions Market Report 2022: Increasing Number of Clinical Trials Driving Growth
September 16, 2022 08:33 ET
|
Research and Markets
Dublin, Sept. 16, 2022 (GLOBE NEWSWIRE) -- The "Global E-Clinical Solutions Market Research and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global...
Clinical Data Analytics Market Demand to Rise at a Staggering 25.7% CAGR amid Rising Need for Improving Patient Care | Future Market Insights, Inc.
September 07, 2022 08:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Sept. 07, 2022 (GLOBE NEWSWIRE) -- According to Future Market Insights (FMI), the global clinical data analytics is anticipated to grow at a CAGR of 25.7% during the forecast period,...
Entera Bio Announces Execution of Key Regulatory Milestones for EB613, the First Oral Anabolic Drug Proposed for the Treatment of Osteoporosis; Miranda Toledano Assumes CEO Position
July 18, 2022 07:05 ET
|
Entera Bio Ltd.
JERUSALEM, July 18, 2022 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered peptides and therapeutic proteins, announced today the execution of the...
Real-world Evidence (RWE) Solutions Market Worth $4.9 Billion by 2029 - Exclusive Report by Meticulous Research®
July 11, 2022 09:00 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, July 11, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Real-World Evidence Solutions Market by Component (Datasets [Clinical, Claims, Pharmacy,...
Top International Academic Institutions Complete Independent Studies Validating C-POLAR™ Technology
July 05, 2022 08:00 ET
|
C-Polar Technologies
LAS VEGAS, July 05, 2022 (GLOBE NEWSWIRE) -- C-POLAR™ Technologies Inc., a bioprotection company dedicated to setting the new standard of health and safety through the protection against viruses and...
iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials
June 08, 2022 07:00 ET
|
iSTAR Medical
For immediate release iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials Analysis provides further validation of MINIject®’s meaningful and...
iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials
June 08, 2022 02:00 ET
|
iSTAR Medical
For immediate release iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials Analysis provides further validation of MINIject®’s meaningful and...
The Worldwide Healthcare Data Collection and Labeling Industry is Expected to Reach $4.5 Billion by 2030
May 30, 2022 07:48 ET
|
Research and Markets
Dublin, May 30, 2022 (GLOBE NEWSWIRE) -- The "Healthcare Data Collection and Labeling Market Size, Share & Trends Analysis Report by Data Type (Image/Video, Audio, Text), by Region (North...
Caribou Biosciences Announces Positive Initial Data for CB-010 Anti-CD19 Allogeneic CAR-T Cell Therapy
May 12, 2022 10:00 ET
|
Caribou Biosciences, Inc.
-- 100% ORR (5 of 5 patients) and 80% CR (4 of 5 patients) achieved following 1 dose at the initial dose level in patients with aggressive r/r B-NHL -- -- CB-010 is the 1st allogeneic CAR-T cell...
Clarus Therapeutics to Present New Data for JATENZO® (testosterone undecanoate) at the 2022 American Urological Association Annual Meeting
May 09, 2022 09:05 ET
|
Clarus Therapeutics Holdings, Inc.
JATENZO is the first FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions NORTHBROOK, Ill., May 09, 2022 ...